Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2011 Mar 24;6(4):626–639. doi: 10.1007/s11481-011-9272-9

Table 2. Timeline of mortality and the underlying pathology in the infected macaques.

Mortality in the M+V group was as early as 5 weeks PI (3/8 animals) compared to 13 weeks PI in the V group (1/4 animals). Three out of five of the M+V rapid progressors died of meningitis/encephalitis and pneumonia whereas one died of lymphoma. The rapid progressor in the V group had mild encephalitis.

Animal ID Treatment Death (p.i) Weeks Encephalitis Other Diagnosis
Rapid Progressors A1 M+V 13 Mild Pneumonia
B4 M+V 5 Moderate Meningitis, Pneumonia
B5 M+V 5 Moderate Meningitis, Pneumonia
B6 M+V 5 None Meningitis, Pneumonia
B2 M+V 16 None Follicular lymphoma of spleen, moderate lung congestion, GALT & IN hyperplasia
C3 V 13 Mild Pneumonia
Long-term Progressors A2 M+V 51 Moderate Pneumonia
A3 M+V 51 Mild Meningoencephalitis
A4 M+V 51 Mild Pneumonia
B3 M+V 51 Mild Pneumonia
C1 V 52 Mild Meningitis
C2 V 52 Moderate Pneumonia
C4 V 52 Mild Meningitis, Pneumonia